In addition to therapies such as HybO2, recent findings found that two patients who have taken a medication developed by Pfizer, known as antiviral Paxlovid, have been said to have recovered and “found relief”.
The first, a smaller group of people with respiratory symptoms, such as a cough or breathlessness (this group was more likely to have had severe Covid illness initially), and the second, a larger group with a cluster of more general symptoms, particularly tiredness and fatigue.
In addition to therapies such as HybO2, recent findings, found that two patients who have taken a medication developed by Pfizer, known as antiviral Paxlovid, have been said to have recovered and “found relief”.
One of these two patients was a researcher who tested the drug on herself, was able to provide “intriguing evidence for clinical trials to help those suffering from the debilitating condition”.